Unloaded tolDCs substantially lowered the effect of diabetogenic T cells (100–50%) and slightly more compared to the whole diabetogenic splenocytes (100–37.5%), whereas autoantigen-loaded tolDCs-GAD65 again failed to prevent diabetes in NOD-SCID recipients. The gene discussed is GAD2; the disease is diabetes mellitus.